We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+4.01%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$6.7B
AUM Growth
+$144M
Cap. Flow
+$80.4M
Cap. Flow %
1.2%
Top 10 Hldgs %
21%
Holding
1,675
New
169
Increased
710
Reduced
579
Closed
127

Top Buys

Rank Stock Value
1
DNOV icon
FT Vest US Equity Deep Buffer ETF November
DNOV
+$21.1M
2
IWP icon
iShares Russell Mid-Cap Growth ETF
IWP
+$12.8M
3
ZTS icon
Zoetis
ZTS
+$7M
4
MPLX icon
MPLX
MPLX
+$6.88M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$5.9M

Top Sells

Rank Stock Value
1
DMAR icon
FT Vest US Equity Deep Buffer ETF March
DMAR
+$21.8M
2
VZ icon
Verizon
VZ
+$11M
3
NVDA icon
NVIDIA
NVDA
+$7.29M
4
IIPR icon
Innovative Industrial Properties
IIPR
+$6.32M
5
BIL icon
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
+$5.96M

Sector Composition

Rank Sector Weight
1 Technology 21.11%
2 Financials 10.66%
3 Industrials 8.29%
4 Consumer Discretionary 7.5%
5 Healthcare 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BB icon
1526
BlackBerry
BB
$4.98B
$58.2K ﹤0.01%
15,385
-19,633
-56% -$52.2K
DHY
1527
Credit Suisse High Yield Credit Fund
DHY
$242M
$54K ﹤0.01%
25,255
– –
SVRA icon
1528
Savara
SVRA
$1.12B
$47.9K ﹤0.01%
15,600
-100,004
-87% -$349K
MDXH icon
1529
MDxHealth
MDXH
$21.5M
$47.4K ﹤0.01%
20,000
+10,000
+100% +$20.4K
SLQT icon
1530
SelectQuote
SLQT
$132M
$46.6K ﹤0.01%
+12,526
New +$32K
MLSS icon
1531
Milestone Scientific
MLSS
$35.3M
$40.8K ﹤0.01%
42,500
– –
PRME icon
1532
Prime Medicine
PRME
$527M
$35.4K ﹤0.01%
12,106
-5,765
-32% -$20.2K
SEED icon
1533
Origin Agritech
SEED
$12.1M
$31.5K ﹤0.01%
15,000
+1,000
+7% +$2.62K
GEG icon
1534
Great Elm Group
GEG
$67.4M
$29.5K ﹤0.01%
16,272
-3,892
-19% -$7.07K
OCGN icon
1535
Ocugen
OCGN
$416M
$29.1K ﹤0.01%
36,155
– –
TMC icon
1536
TMC The Metals Company
TMC
$1.54B
$28.2K ﹤0.01%
+25,220
New +$23.8K
PLUG icon
1537
Plug Power
PLUG
$2.87B
$24.8K ﹤0.01%
+11,636
New +$25.4K
ALLO icon
1538
Allogene Therapeutics
ALLO
$649M
$22.4K ﹤0.01%
10,500
– –
ARAY icon
1539
Accuray
ARAY
$32M
$21.8K ﹤0.01%
11,000
– –
BARK icon
1540
BARK
BARK
$81.8M
$21.2K ﹤0.01%
575
– –
CNBS icon
1541
Amplify Seymour Cannabis ETF
CNBS
$70.6M
$20.5K ﹤0.01%
+833
New +$36.4K
ADAP
1542
DELISTED
Adaptimmune Therapeutics
ADAP
$17.3K ﹤0.01%
32,043
-4,232
-12% -$3.08K
FUBO icon
1543
FuboTV Inc
FUBO
$261M
$15.9K ﹤0.01%
1,049
– –
CLSD
1544
DELISTED
Clearside Biomedical
CLSD
$13.6K ﹤0.01%
+956
New +$15.7K
WRN
1545
Western Copper and Gold
WRN
$460M
$10.5K ﹤0.01%
10,000
– –
RVP icon
1546
Retractable Technologies
RVP
$19.8M
$10.3K ﹤0.01%
15,020
– –
IAUX
1547
i-80 Gold Corp
IAUX
$1.11B
$5.65K ﹤0.01%
11,650
+250
+2% +$202
CLRB icon
1548
Cellectar Biosciences
CLRB
$20.5M
$3.74K ﹤0.01%
417
– –
AAL icon
1549
American Airlines Group
AAL
$10.1B
– –
-10,895
Closed -$122K
AAOI icon
1550
Applied Optoelectronics
AAOI
$7.57B
– –
-13,017
Closed -$186K
60 61
62
63 64

Similar funds

LGF
LGT Group Foundation Vaduz, Liechtenstein $8.19B AUM 27.7% 1-Year Est. Return
CCM
Causeway Capital Management Los Angeles, California $8.15B AUM 29.28% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $8.15B AUM 20.12% 1-Year Est. Return
WJWM
Williams Jones Wealth Management New York $8.14B AUM 19.32% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return
AIM
Allen Investment Management New York $8.09B AUM 16.78% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Oppenheimer & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Oppenheimer & Co held 1,675 positions worth $6.7B, up 2.2% from $6.56B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Oppenheimer & Co's Q4 2024 filing shows 169 new, 710 increased, 579 reduced and 127 closed positions. Its largest new stake was FT Vest US Equity Deep Buffer ETF November: 493,441 shares worth $21.2M. The largest sale was FT Vest US Equity Deep Buffer ETF March, an estimated $21.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Industrials.

  • Oppenheimer & Co's largest Q4 2024 buy was FT Vest US Equity Deep Buffer ETF November: 493,441 shares worth $21.2M.
  • Oppenheimer & Co added most to iShares Russell Mid-Cap Growth ETF in Q4 2024, an estimated $12.8M increase.
  • Oppenheimer & Co's biggest Q4 2024 reduction was FT Vest US Equity Deep Buffer ETF March, cutting an estimated $21.8M.
  • Oppenheimer & Co fully exited Innovative Industrial Properties in Q4 2024, selling an estimated $6.32M.
  • Oppenheimer & Co's ten largest holdings make up 21% of its $6.7B portfolio in Q4 2024.
  • Oppenheimer & Co opened 169 new positions and closed 127 in Q4 2024.
  • Oppenheimer & Co's portfolio value rose 2.2% quarter-over-quarter to $6.7B.

Based on Oppenheimer & Co's 13F filing for Q4 2024, filed 5 Feb 2025.